Marco Colella

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

BRD4 contributes to the cytokine-induced acquisition of an IL-13RA2-positive inflammatory fibroblast phenotype.

BRD4 contributes to the cytokine-induced acquisition of an IL-13RA2-positive inflammatory fibroblast phenotype.

Journal: Journal of Crohn's & colitis
Published: August 24, 2026

SMAD7-Associated Glycolytic Regulation Promotes Lactate-Dependent Macrophage Phenotype Modulation in Colorectal Cancer.

SMAD7-Associated Glycolytic Regulation Promotes Lactate-Dependent Macrophage Phenotype Modulation in Colorectal Cancer.

Journal: Cancers
Published: July 08, 2026

Bromodomain-containing protein 4 in inflammatory diseases: molecular mechanisms and therapeutic potential.

Bromodomain-containing protein 4 in inflammatory diseases: molecular mechanisms and therapeutic potential.

Journal: Journal of inflammation (London, England)
Published: December 09, 2025

Bromodomain-containing 4 as a therapeutic target in inflammatory bowel diseases and colorectal cancer.

Bromodomain-containing 4 as a therapeutic target in inflammatory bowel diseases and colorectal cancer.

Journal: Frontiers in pharmacology
Published: August 08, 2025

Smad7 is a negative regulator of immunogenic cell death in colorectal cancer.

Smad7 is a negative regulator of immunogenic cell death in colorectal cancer.

Journal: Oncoimmunology
Published: April 11, 2025

High Smad7 marks inflammation in patients with chronic pouchitis.

High Smad7 marks inflammation in patients with chronic pouchitis.

Journal: Frontiers in immunology
Published: December 20, 2024

The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications.

The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications.

Journal: Biomolecules
Published: December 11, 2024

Hepcidin Is a Valuable Therapeutic Target for Colorectal Cancer.

Hepcidin Is a Valuable Therapeutic Target for Colorectal Cancer.

Journal: Cancers
Published: November 13, 2024

Loss of Adenosine Deaminase Acting on RNA 1 Induces Panoptosis and Immune Response in Ulcerative Colitis Gut Mucosa.

Loss of Adenosine Deaminase Acting on RNA 1 Induces Panoptosis and Immune Response in Ulcerative Colitis Gut Mucosa.

Journal: MedComm
Published: September 06, 2024

SMAD7 Sustains XIAP Expression and Migration of Colorectal Carcinoma Cells.

SMAD7 Sustains XIAP Expression and Migration of Colorectal Carcinoma Cells.

Journal: Cancers
Published: May 24, 2024

Insulin-like Growth Factor II mRNA-Binding Protein 1 Regulates Pancreatic Cancer Cell Growth through the Surveillance of CDC25A mRNA.

Insulin-like Growth Factor II mRNA-Binding Protein 1 Regulates Pancreatic Cancer Cell Growth through the Surveillance of CDC25A mRNA.

Journal: Cancers
Published: July 26, 2023

Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance.

Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance.

Journal: Cancers
Published: November 22, 2022
Showing 1-12 of 17

Last Updated: 09/26/2026